top of page
Fzata Awards
​
-
"Finalist" at BIO 2024 International Start-up Stadium
-
$7MM grant award supports Visceral Pain FZ006 program, 2024
-
A winner of the Global Health Innovation Challenge II
Our MISSION
Expand safety, efficacy & access for therapeutic biologics leveraging BioPYM oral administration
Fzata oral biologics benefits include:
​1. Manufacturing - no cold chain, low cost of goods, scalable​
2. Patient QoL -no needles, no infusions, no refrigeration
3. Clinical - steady GI drug levels, no toxicities, no ADA, no immunosuppressants
​​
The Fzata proprietary oral Bioengineered Probiotic Yeast Medicines (BioPYM) uses yeast micro-factories to make biologic therapeutics “on-site” in the gut for treatment of GI diseases and gut-brain axis disorders.  
​

Intro Video 2 min.

Fzata, Inc. 1450 S. Rolling Rd, Room 4.097, Halethorpe, Maryland 21227 USA
443.543.5040 info (type @) fzata.com
bottom of page